Literature DB >> 6817926

Posttranslational formation of hypusine in a single major protein occurs generally in growing cells and is associated with activation of lymphocyte growth.

H L Cooper, M H Park, J E Folk.   

Abstract

Growing lymphocytes perform a novel chemical modification of a single protein (Hy+: approximately 18 kd, pI approximately 5.1), resulting in the formation of the unusual amino acid, hypusine (N epsilon-[4-amino-2-hydroxybutyl]lysine). This posttranslational event occurs only following activation of lymphocyte growth. Hypusine formation increases at a rate parallel to protein synthesis during the first 24 hr of growth stimulation, beginning before 6 hr of growth. At all times, hypusine is restricted primarily to the single protein, Hy+. In resting cells, the unmodified substrate protein, Hy0, is continuously synthesized and maintained in a steady-state pool of significant size. In several other cell lines, hypusine formation was also observed in a single protein of approximately 18 kd, pI approximately 5.1, indistinguishable electrophoretically from the lymphocyte protein. Thus Hy+ is a ubiquitous protein showing significant conservation among divergent species. Maintenance by resting lymphocytes of a pool of unmodified protein and early activation during growth of the hypusine-forming enzyme system suggest that this posttranslational modification may be of importance to lymphocyte activation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6817926     DOI: 10.1016/0092-8674(82)90441-x

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  29 in total

1.  The polyamine-derived amino acid hypusine: its post-translational formation in eIF-5A and its role in cell proliferation.

Authors:  M H Park; Y A Joe; K R Kang; Y B Lee; E C Wolff
Journal:  Amino Acids       Date:  1996-06       Impact factor: 3.520

Review 2.  The hypusine-containing translation factor eIF5A.

Authors:  Thomas E Dever; Erik Gutierrez; Byung-Sik Shin
Journal:  Crit Rev Biochem Mol Biol       Date:  2014-07-17       Impact factor: 8.250

3.  Biological Relevance and Therapeutic Potential of the Hypusine Modification System.

Authors:  Nora Pällmann; Melanie Braig; Henning Sievert; Michael Preukschas; Irm Hermans-Borgmeyer; Michaela Schweizer; Claus Henning Nagel; Melanie Neumann; Peter Wild; Eugenia Haralambieva; Christian Hagel; Carsten Bokemeyer; Joachim Hauber; Stefan Balabanov
Journal:  J Biol Chem       Date:  2015-06-02       Impact factor: 5.157

Review 4.  Monitoring protein communities and their responses to therapeutics.

Authors:  Hanna G Budayeva; Donald S Kirkpatrick
Journal:  Nat Rev Drug Discov       Date:  2020-03-05       Impact factor: 84.694

5.  Interferon alpha2 recombinant and epidermal growth factor modulate proliferation and hypusine synthesis in human epidermoid cancer KB cells.

Authors:  M Caraglia; A Passeggio; S Beninati; A Leardi; L Nicolini; S Improta; A Pinto; A R Bianco; P Tagliaferri; A Abbruzzese
Journal:  Biochem J       Date:  1997-06-15       Impact factor: 3.857

6.  Hypusine modification for growth is the major function of spermidine in Saccharomyces cerevisiae polyamine auxotrophs grown in limiting spermidine.

Authors:  Manas K Chattopadhyay; Myung Hee Park; Herbert Tabor
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-01       Impact factor: 11.205

7.  gamma-Glutamylamine derivatives in isolated rat hepatocyte proteins.

Authors:  M Piacentini; S Beninati
Journal:  Biochem J       Date:  1988-02-01       Impact factor: 3.857

8.  Transglutaminases and the clotting of mammalian seminal fluids.

Authors:  H G Williams-Ashman
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

9.  PCR-based cloning of the full-length Neurospora eukaryotic initiation factor 5A cDNA: polyhistidine-tagging and overexpression for protein affinity binding.

Authors:  Y Tao; K Y Chen
Journal:  Biochem J       Date:  1994-09-01       Impact factor: 3.857

10.  Induced gene expression of the hypusine-containing protein eukaryotic initiation factor 5A in activated human T lymphocytes.

Authors:  D Bevec; H Klier; W Holter; E Tschachler; P Valent; F Lottspeich; T Baumruker; J Hauber
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.